oYo-Link® Antibody-Drug Conjugation Reagents

Enhanced precision and control for rapid ADC prototyping.

Choose from our DM1, DM4, VcMMAE and VcMMAF products below:

Showing all 4 results

  • oYo-Link® DM1

    Site-specifically label your antibody with oYo-Link® DM1 drug for cell killing

    Find out more
  • oYo-Link® DM4

    Site-specifically label your antibody with oYo-Link® DM4 drug for cell killing assays to

    Find out more
  • oYo-Link® VcMMAE

    Site-specifically label your antibody with oYo-Link® VcMMAE drug for cell killing assays to

    Find out more
  • oYo-Link® VcMMAF

    Site-specifically label your antibody with oYo-Link® DM1 drug for cell killing assays to

    Find out more

oYo-Link® Advantages

Easy & rapid labeling

Reactions require less than 30 seconds hands-on time, 2 hours total.

Covalent, site-specific labeling to the Fc region

No loss in antibody functionality & highly efficient labeling resulting in homogeneous conjugates with 1 to 2 labels per antibody.

Label small amounts

Label as little as 1 µg of antibody at a time and in diluted antibody solutions – 50 µg/mL.

Robust buffer compatibility

No purification steps; 100% sample recovery – no wasting of expensive samples.